Monsanto (MON) Shares Bought by Alpine Associates Management Inc.
Alpine Associates Management Inc. grew its stake in Monsanto (NYSE:MON) by 12.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 1,865,740 shares of the basic materials company’s stock after buying an additional 202,054 shares during the quarter. Monsanto comprises 7.8% of Alpine Associates Management Inc.’s portfolio, making the stock its 3rd largest holding. Alpine Associates Management Inc.’s holdings in Monsanto were worth $217,882,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Retirement Systems of Alabama lifted its stake in Monsanto by 0.5% during the fourth quarter. Retirement Systems of Alabama now owns 257,721 shares of the basic materials company’s stock worth $30,097,000 after purchasing an additional 1,347 shares during the last quarter. Public Employees Retirement System of Ohio lifted its stake in Monsanto by 0.4% during the fourth quarter. Public Employees Retirement System of Ohio now owns 317,401 shares of the basic materials company’s stock worth $37,066,000 after purchasing an additional 1,399 shares during the last quarter. Barings LLC lifted its stake in Monsanto by 205.3% during the fourth quarter. Barings LLC now owns 54,108 shares of the basic materials company’s stock worth $6,319,000 after purchasing an additional 36,385 shares during the last quarter. Sei Investments Co. lifted its stake in Monsanto by 0.3% during the fourth quarter. Sei Investments Co. now owns 193,537 shares of the basic materials company’s stock worth $22,601,000 after purchasing an additional 647 shares during the last quarter. Finally, New Mexico Educational Retirement Board lifted its stake in Monsanto by 3.7% during the fourth quarter. New Mexico Educational Retirement Board now owns 42,266 shares of the basic materials company’s stock worth $4,936,000 after purchasing an additional 1,500 shares during the last quarter. Institutional investors and hedge funds own 74.62% of the company’s stock.
Several equities research analysts recently weighed in on the company. Wells Fargo & Co restated a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Wednesday, November 15th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $127.30.
Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The company had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The company’s revenue for the quarter was up .3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.21 EPS. equities research analysts expect that Monsanto will post 5.76 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Thursday, April 5th. Monsanto’s payout ratio is currently 39.93%.
In other news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.70% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Monsanto (MON) Shares Bought by Alpine Associates Management Inc.” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2018/02/14/monsanto-mon-shares-bought-by-alpine-associates-management-inc.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.